Clinical Trial: Perioperative Systemic Therapies in Muscle-Invasive Bladder Cancer (GUARDIANS)

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07855926) titled 'Perioperative Systemic Therapies in Muscle-Invasive Bladder Cancer (GUARDIANS)' on May 17.

Brief Summary: This is a multicenter, non-interventional, prospective and retrospective observational patient registry study of adults with muscle-invasive bladder cancer receiving perioperative systemic therapy as part of routine clinical care. The registry includes patients treated with perioperative systemic therapies such as Enfortumab Vedotin plus Pembrolizumab as well as cisplatin-based combinations including Gemcitabine/Cisplatin/Durvalumab and other standard perioperative treatment approaches in the neoadjuvant and adjuvant setting.

Th...